These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23330954)

  • 21. Immunology. Close to the edge: neutralizing the HIV-1 envelope.
    Nabel GJ
    Science; 2005 Jun; 308(5730):1878-9. PubMed ID: 15976295
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-2 antisera cross-neutralize HIV-1.
    Weiss RA; Clapham PR; Weber JN; Whitby D; Tedder RS; O'Connor T; Chamaret S; Montagnier L
    AIDS; 1988 Apr; 2(2):95-100. PubMed ID: 3132953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies.
    Nakamura G; Chai N; Park S; Chiang N; Lin Z; Chiu H; Fong R; Yan D; Kim J; Zhang J; Lee WP; Estevez A; Coons M; Xu M; Lupardus P; Balazs M; Swem LR
    Cell Host Microbe; 2013 Jul; 14(1):93-103. PubMed ID: 23870317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.
    Walker LM; Burton DR
    Nat Rev Immunol; 2018 May; 18(5):297-308. PubMed ID: 29379211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic antibodies in HIV treatment--classical approaches to novel advances.
    Abela IA; Reynell L; Trkola A
    Curr Pharm Des; 2010; 16(33):3754-66. PubMed ID: 21128888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006.
    Bansal GP
    Biologicals; 2007 Oct; 35(4):367-71. PubMed ID: 17889555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Searching for Achilles' heel: can rational design of malaria vaccines overcome antigenic diversity?
    Riley EM
    Pathog Glob Health; 2014 Mar; 108(2):63-4. PubMed ID: 24649865
    [No Abstract]   [Full Text] [Related]  

  • 29. Single-Administration Long-Acting Microarray Patch with Ultrahigh Loading Capacity and Multiple Releases of Thermally Stable Antibodies.
    Tran KTM; Le TT; Agrahari V; Peet MM; Ouattara LA; Anderson SM; Le-Kim TH; Singh ON; Doncel GF; Nguyen TD
    Mol Pharm; 2023 May; 20(5):2352-2361. PubMed ID: 37014806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses.
    Wang Q; Huang Z
    Curr Opin Virol; 2022 Aug; 55():101247. PubMed ID: 35803202
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid development of broadly influenza neutralizing antibodies through redundant mutations.
    Pappas L; Foglierini M; Piccoli L; Kallewaard NL; Turrini F; Silacci C; Fernandez-Rodriguez B; Agatic G; Giacchetto-Sasselli I; Pellicciotta G; Sallusto F; Zhu Q; Vicenzi E; Corti D; Lanzavecchia A
    Nature; 2014 Dec; 516(7531):418-22. PubMed ID: 25296253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
    Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
    Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broadly neutralizing antibodies against influenza viruses.
    Laursen NS; Wilson IA
    Antiviral Res; 2013 Jun; 98(3):476-83. PubMed ID: 23583287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.
    Burton DR; Hangartner L
    Annu Rev Immunol; 2016 May; 34():635-59. PubMed ID: 27168247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.
    Lee PS; Wilson IA
    Curr Top Microbiol Immunol; 2015; 386():323-41. PubMed ID: 25037260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
    Corti D; Zhao J; Pedotti M; Simonelli L; Agnihothram S; Fett C; Fernandez-Rodriguez B; Foglierini M; Agatic G; Vanzetta F; Gopal R; Langrish CJ; Barrett NA; Sallusto F; Baric RS; Varani L; Zambon M; Perlman S; Lanzavecchia A
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10473-8. PubMed ID: 26216974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tackling influenza with broadly neutralizing antibodies.
    Corti D; Cameroni E; Guarino B; Kallewaard NL; Zhu Q; Lanzavecchia A
    Curr Opin Virol; 2017 Jun; 24():60-69. PubMed ID: 28527859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 neutralizing antibodies: understanding nature's pathways.
    Mascola JR; Haynes BF
    Immunol Rev; 2013 Jul; 254(1):225-44. PubMed ID: 23772623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Methods To Isolate Human Monoclonal Antibodies from Memory B Cells and Plasma Cells.
    Corti D; Lanzavecchia A
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors.
    Zhou T; Lynch RM; Chen L; Acharya P; Wu X; Doria-Rose NA; Joyce MG; Lingwood D; Soto C; Bailer RT; Ernandes MJ; Kong R; Longo NS; Louder MK; McKee K; O'Dell S; Schmidt SD; Tran L; Yang Z; Druz A; Luongo TS; Moquin S; Srivatsan S; Yang Y; Zhang B; Zheng A; Pancera M; Kirys T; Georgiev IS; Gindin T; Peng HP; Yang AS; ; Mullikin JC; Gray MD; Stamatatos L; Burton DR; Koff WC; Cohen MS; Haynes BF; Casazza JP; Connors M; Corti D; Lanzavecchia A; Sattentau QJ; Weiss RA; West AP; Bjorkman PJ; Scheid JF; Nussenzweig MC; Shapiro L; Mascola JR; Kwong PD
    Cell; 2015 Jun; 161(6):1280-92. PubMed ID: 26004070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.